Bio-Rad Laboratories PE Ratio 2010-2023 | BIO
Current and historical p/e ratio for Bio-Rad Laboratories (BIO) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Bio-Rad Laboratories PE ratio as of March 28, 2024 is 29.70.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Bio-Rad Laboratories PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-03-28 | 345.87 | 0.00 | |
2023-12-31 | 322.89 | $-21.49 | 0.00 |
2023-09-30 | 358.45 | $-5.85 | 0.00 |
2023-06-30 | 379.12 | $-15.01 | 0.00 |
2023-03-31 | 479.02 | $-6.54 | 0.00 |
2022-12-31 | 420.49 | $-121.43 | 0.00 |
2022-09-30 | 417.14 | $-201.80 | 0.00 |
2022-06-30 | 495.00 | $-66.32 | 0.00 |
2022-03-31 | 563.23 | $-4.88 | 0.00 |
2021-12-31 | 755.57 | $140.07 | 5.39 |
2021-09-30 | 745.95 | $220.47 | 3.38 |
2021-06-30 | 644.29 | $134.15 | 4.80 |
2021-03-31 | 571.17 | $135.98 | 4.20 |
2020-12-31 | 582.94 | $126.32 | 4.61 |
2020-09-30 | 515.46 | $116.82 | 4.41 |
2020-06-30 | 451.49 | $64.50 | 7.00 |
2020-03-31 | 350.56 | $52.21 | 6.71 |
2019-12-31 | 370.03 | $58.23 | 6.35 |
2019-09-30 | 332.74 | $12.04 | 27.64 |
2019-06-30 | 312.59 | $29.61 | 10.56 |
2019-03-31 | 305.68 | $18.62 | 16.42 |
2018-12-31 | 232.22 | $11.65 | 19.93 |
2018-09-30 | 312.99 | $41.85 | 7.48 |
2018-06-30 | 288.54 | $33.87 | 8.52 |
2018-03-31 | 250.08 | $25.17 | 9.94 |
2017-12-31 | 238.67 | $3.81 | 62.64 |
2017-09-30 | 222.22 | $0.79 | 281.29 |
2017-06-30 | 226.31 | $0.50 | 452.62 |
2017-03-31 | 199.34 | $0.94 | 212.06 |
2016-12-31 | 182.28 | $0.95 | 191.87 |
2016-09-30 | 163.81 | $3.33 | 49.19 |
2016-06-30 | 143.02 | $3.30 | 43.34 |
2016-03-31 | 136.72 | $3.66 | 37.36 |
2015-12-31 | 138.66 | $3.85 | 36.02 |
2015-09-30 | 134.31 | $3.51 | 38.26 |
2015-06-30 | 150.61 | $3.31 | 45.50 |
2015-03-31 | 135.18 | $3.43 | 39.41 |
2014-12-31 | 120.56 | $3.05 | 39.53 |
2014-09-30 | 113.40 | $2.75 | 41.24 |
2014-06-30 | 119.71 | $2.11 | 56.73 |
2014-03-31 | 128.12 | $2.22 | 57.71 |
2013-12-31 | 123.61 | $2.67 | 46.30 |
2013-09-30 | 117.56 | $3.28 | 35.84 |
2013-06-30 | 112.20 | $5.01 | 22.40 |
2013-03-31 | 126.00 | $5.50 | 22.91 |
2012-12-31 | 105.05 | $5.91 | 17.77 |
2012-09-30 | 106.72 | $6.34 | 16.83 |
2012-06-30 | 100.01 | $6.47 | 15.46 |
2012-03-31 | 103.69 | $6.19 | 16.75 |
2011-12-31 | 96.04 | $6.26 | 15.34 |
2011-09-30 | 90.77 | $6.59 | 13.77 |
2011-06-30 | 119.36 | $6.57 | 18.17 |
2011-03-31 | 120.14 | $6.51 | 18.45 |
2010-12-31 | 103.85 | $6.59 | 15.76 |
2010-09-30 | 90.51 | $5.53 | 16.37 |
2010-06-30 | 86.49 | $5.32 | 16.26 |
2010-03-31 | 103.52 | $5.34 | 19.39 |
2009-12-31 | 96.46 | $5.20 | 18.55 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $9.969B | $2.671B |
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $196.909B | 25.56 |
Stryker (SYK) | United States | $136.478B | 33.84 |
Medtronic (MDT) | Ireland | $115.414B | 16.34 |
EssilorLuxottica (ESLOY) | France | $103.810B | 0.00 |
Boston Scientific (BSX) | United States | $100.864B | 33.47 |
Lonza Group Ag (LZAGY) | Switzerland | $44.257B | 0.00 |
Haleon (HLN) | United Kingdom | $39.385B | 30.46 |
ResMed (RMD) | United States | $28.878B | 28.87 |
Terumo (TRUMY) | Japan | $27.930B | 39.32 |
Zimmer Biomet Holdings (ZBH) | United States | $27.196B | 17.54 |
Baxter (BAX) | United States | $21.679B | 15.81 |
Koninklijke Philips (PHG) | Netherlands | $18.879B | 15.06 |
Insulet (PODD) | United States | $11.830B | 62.20 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.515B | 0.00 |
Demant (WILYY) | Denmark | $11.278B | 0.00 |
BellRing Brands (BRBR) | United States | $7.702B | 41.41 |
Haemonetics (HAE) | United States | $4.271B | 21.84 |
Perrigo (PRGO) | Ireland | $4.263B | 12.19 |
GN Store Nord (GNNDY) | Denmark | $4.150B | 26.87 |
Lantheus Holdings (LNTH) | United States | $4.145B | 10.70 |
Envista Holdings (NVST) | United States | $3.697B | 14.09 |
Prestige Consumer Healthcare (PBH) | United States | $3.606B | 17.05 |
Neogen (NEOG) | United States | $3.347B | 32.21 |
QuidelOrtho (QDEL) | United States | $3.226B | 11.71 |
Green Thumb Industries (GTBIF) | United States | $3.155B | 100.00 |
ICU Medical (ICUI) | United States | $2.484B | 18.71 |
TG Therapeutics (TGTX) | United States | $2.404B | 778.50 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.157B | 0.00 |
Verano Holdings (VRNOF) | United States | $2.151B | 0.00 |
Owens & Minor (OMI) | United States | $2.141B | 20.55 |
InMode (INMD) | Israel | $1.780B | 9.22 |
National Vision Holdings (EYE) | United States | $1.720B | 53.56 |
Agios Pharmaceuticals (AGIO) | United States | $1.636B | 0.00 |
AdaptHealth (AHCO) | United States | $1.510B | 11.36 |
LeMaitre Vascular (LMAT) | United States | $1.499B | 49.78 |
AtriCure (ATRC) | United States | $1.458B | 0.00 |
Warby Parker (WRBY) | United States | $1.303B | 0.00 |
MacroGenics (MGNX) | United States | $0.934B | 0.00 |
Quanterix (QTRX) | United States | $0.873B | 0.00 |
Canopy Growth (CGC) | Canada | $0.870B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.836B | 0.00 |
Evolus (EOLS) | United States | $0.811B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.771B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.716B | 15.47 |
TerrAscend (TSNDF) | Canada | $0.571B | 0.00 |
Valneva SE (VALN) | France | $0.553B | 0.00 |
Jin Medical (ZJYL) | China | $0.543B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.529B | 11.46 |
PetIQ (PETQ) | United States | $0.513B | 19.17 |
OraSure Technologies (OSUR) | United States | $0.470B | 7.77 |
ZimVie (ZIMV) | United States | $0.442B | 27.18 |
Biote (BTMD) | United States | $0.438B | 4.16 |
Surmodics (SRDX) | United States | $0.410B | 44.31 |
Zynex (ZYXI) | United States | $0.405B | 46.59 |
Viemed Healthcare (VMD) | United States | $0.364B | 36.08 |
Cerus (CERS) | United States | $0.325B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.322B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.259B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.252B | 15.36 |
TriSalus Life Sciences (TLSI) | United States | $0.248B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.216B | 0.00 |
Omeros (OMER) | United States | $0.215B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.213B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.189B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.183B | 0.00 |
High Tide (HITI) | Canada | $0.163B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.146B | 0.00 |
Fonar (FONR) | United States | $0.138B | 11.84 |
InterCure (INCR) | Israel | $0.115B | 19.46 |
Societal CDMO (SCTL) | United States | $0.115B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.114B | 0.00 |
FitLife Brands (FTLF) | United States | $0.106B | 20.70 |
MariMed (MRMD) | United States | $0.102B | 0.00 |
Safety Shot (SHOT) | United States | $0.094B | 0.00 |
Chimerix (CMRX) | United States | $0.090B | 0.00 |
Veru (VERU) | United States | $0.089B | 0.00 |
Brainsway (BWAY) | Israel | $0.087B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.084B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.080B | 43.99 |
Zevia PBC (ZVIA) | United States | $0.075B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.065B | 4.25 |
Cytosorbents (CTSO) | United States | $0.050B | 0.00 |
Apyx Medical (APYX) | United States | $0.049B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
Bright Green (BGXX) | United States | $0.047B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.045B | 0.00 |
Modular Medical (MODD) | United States | $0.043B | 0.00 |
ImmuCell (ICCC) | United States | $0.041B | 0.00 |
United-Guardian (UG) | United States | $0.036B | 13.85 |
FSD PHARMA (HUGE) | Canada | $0.028B | 0.00 |
Agape ATP (ATPC) | $0.027B | 0.00 | |
Exagen (XGN) | United States | $0.027B | 0.00 |
Nephros (NEPH) | United States | $0.024B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.020B | 0.00 |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
ProSomnus (OSA) | United States | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
GlucoTrack (GCTK) | United States | $0.007B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.001B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |